| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |